期刊文献+

CT的肾血流重建3D影像在内生型肾癌保留肾单位手术中的应用 被引量:2

Application of 3D renal blood flow in laparoscopic nephron sparing surgery for endogenetic kidney cancer
原文传递
导出
摘要 目的探讨CT的肾血流重建3D影像在内生型肾癌保留肾单位手术(LNSS)中的应用。方法术前通过肾肿瘤血流在CT增强中的“快进快退”表现,对患肾进行CT肾血流重建,旋转3D重建影像见肿瘤区域缺损。术中同轴旋转影像及。肾脏,根据缺损部位定位肿瘤,并进行LNSS。结果4例患者均完成LNSS,剥离出肿瘤均见包膜完整,肿瘤直径(2.2±0.5)cm。术中热缺血时间17~27min,平均21.7min。出血20—55mL,平均32mL。病理回示均为透明细胞癌。术后随访7个月一5年,患者血肌酐、尿素氮及碱性磷酸酶无明显变化,肾小球滤过率测定患肾功能无明显下降,CT均未见局部肿瘤复发。结论采用CT的肾血流重建3D影像帮助内生型T1a期肾癌的LNSS进行精准定位,该技术是安全、有效的,并且方法简便易行,利于推广。 Objectives To investigate the application of 3D renal blood flow in laparoscopic nephron sparing surgery(LNSS) for endogenetic kidney cancer by CT imaging. Methods All patients underwent CT renal blood flow reconstruction by "fast" manifestation of preoperative renal tumor blood flow in CT enhancement. All cases underwent LNSS by rotating the inmage and targeting the tumor. Results 4 patients were successfully completed LNSS, the tumor diameter was (2.2 + 0.5) cm. Intraoperative ischemia time was 17 - 27min ( the mean time of 21.7min), amount of bleeding (20 55mL, an average of 32mL). The pathological change was clear cell carcinoma. The blood creatinine, blood urea nitrogen and alkaline phosphatase were not significantly differences during 7 - 60 months follow - up, and the renal function was not significantly decreased, and there was no tumor recurrence in CT. Conclusions 3D renal blood flow can realizes the fine accurate localization for the Tla phase endogenetic kidney cancer, and it is safe, simple and effective, and worth popularizing application in clinic.
出处 《国际泌尿系统杂志》 2016年第4期506-508,共3页 International Journal of Urology and Nephrology
关键词 肾肿瘤 肾单位 体层摄影术 X线计算机 Kidney Neoplasms Nephrons Tomography, X - Ray Computed
  • 相关文献

参考文献10

二级参考文献34

  • 1杨新国.螺旋CT双期增强扫描诊断小肾癌的价值(附12例报告)[J].山东医药,2005,45(14):51-52. 被引量:4
  • 2钟文招,陈义雄,夏俊.螺旋CT在小肾癌诊断中的价值[J].实用放射学杂志,2006,22(5):574-576. 被引量:18
  • 3李玉林.病理学.6版.北京:人民卫生出版社,2006:289-291.
  • 4李松年.现代全身诊断学.北京:中国医药科技出版社,2004:826-835.
  • 5Cooperberg M R,Mallin K,Ritchey J,et al.Decreasing size at diagnosis of stage 1 renal cell carcinoma:analysis from the National Cancer Data Base,1993 to 2004[J].J Urol,2008,179:2131-2135.
  • 6Decastro G J,McKiernan J M.Epidemiology,clinical staging,and presentation of renal cell carcinoma[J].Urol Clin North Am,2008,35:581-592.
  • 7Rothman J,Egleston B,Wong Y N,et al.Histopathological characteristics of localized renal cell carcinoma correlate with tumor size:a SEER analysis[J].J Urol,2009,181:29-34.
  • 8Schlomer B,Robert S.Figenshau Y,et al.Pathological Features of Renal Neoplasms Classified by Size and Symptomatology[J].J Urol,2006,176:1317-1320.
  • 9Kunkle D A,Crispen P L,Li T,et al.Tumor Size Predicts Synchronous Metastatic Renal Cell Carcinoma:Implications for Surveillance of Small Renal Masses[J].J Urol,2007,177:1692-1697.
  • 10Patard J J,Choueiri b T K,Lechevallier E,et al.Recent Developments in Research on Kidney Cancer:Highlights from Urological and Oncological Congresses in 2007[J].Eur Urol Suppl 7,2008:494-507.

共引文献1444

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部